Indications

Heading 1

Paragraph

When it comes to MDS-related anemia,

THIS IS WHERE  I DRAW THE LINE

“I will not be defined by MDS-related anemia. I am not good with good enough. I told my doctor about my goals and he said REBLOZYL® could be the right place to start.”

Heading 1

Paragraph

 

The first and only medicine of its kind​ in MDS-related anemia


Early treatment for anemia is an important part of managing myelodysplastic syndromes (MDS).

Horizontal Rule

Gradient Rule

Full - Purple to pink 

purple and pink horizontal line

Full - Pink to Purple

pink and purple horizontal line

Half - Purple to pink 

purple and pink horizontal line

Buttons

Primary

Secondary

Back to Top

Call-to-Action

2 column

Share to Inspire logo

If the person you are caring for is being treated with REBLOZYL, we’d love to hear your stories. Your story could help other patients and caregivers along their journey. Visit ShareToInspire.com or call us toll-free at 1-855-436-5866.

2 column with background color

Hear from someone who has managed MDS-related anemia with REBLOZYL.

If you’re being treated with REBLOZYL, we’d love to hear your story. Your story could help other patients and caregivers along their journey. Visit ShareToInspire.com or call us toll-free at 1-855-436-5866.



swoosh

This website is intended for U.S. residents 18 years of age or older.

REBLOZYL® is a trademark of Celgene Corporation, a Bristol Myers Squibb company.

Access Support® and Your REBLOZYL Connection are trademarks of Bristol-Myers Squibb Company.

REBLOZYL® is licensed from Merck & Co. Inc., Rahway, NJ, USA and its affiliates.

© 2025 Bristol-Myers Squibb Company.

2007-US-2500017  1/25